Intellego Technologies AB

INT

SE0016075063

Biotechnology & Medical Research

Delayed Nasdaq Stockholm Other stock markets 12:00:10 2025-11-17 pm EST			5-day change	1st Jan Change
46.55 ^SEK	+4.96%		-.--%	+13.54%

Dec. 12	Several Links Between Dug Foodtech and Intellego Revealed by Di's Investigation (R)	FW
Dec. 11	Court of Appeal Upholds Freeze on Intellego's SEK 230 Million	FW

Sweden's Intellego Technologies Signs Sales, Marketing Rights Deal in US

Published on 01/14/2025 at 06:03 am EST - Modified on 01/14/2025 at 06:05 am EST

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Intellego Technologies AB

Dec. 12	Several Links Between Dug Foodtech and Intellego Revealed by Di's Investigation (R)	FW
Dec. 11	Court of Appeal Upholds Freeze on Intellego's SEK 230 Million	FW
Dec. 10	Intellego appeals asset freeze	RE
Dec. 10	Intellego Appeals to Access Frozen Funds - Di	FW
Dec. 09	EBM Will Not Launch Preliminary Investigation for Fraudulent Conduct in Intellego Case	FW
Dec. 05	More Individuals Suspected in Intellego Investigation - Di	FW
Dec. 04	Intellego Fraud Suspect CEO Claes Lindahl Released from Custody	FW
Dec. 04	Multiple Links Between Dug Foodtech and Intellego Revealed by Di Investigation	FW
Dec. 04	Intellego granted additional time to respond to Nasdaq	RE
Dec. 04	Intellego Granted Extension to Respond to Nasdaq	FW
Nov. 28	Intellego says Deloitte to submit report of accounting fraud suspicion	RE
Nov. 28	Deloitte Suspects Accounting Fraud at Intellego	FW
Nov. 26	Intellego Technologies dismisses CEO, engages KPMG for investigation	RE
Nov. 26	Intellego Engages KPMG for Independent Investigation	FW
Nov. 26	EBM Now Suspects Aggravated Fraud in Intellego Scandal - SEK and EKN File Police Report	FW
Nov. 26	EBM Requests Additional Asset Freeze of 130 Million SEK in Intellego Scandal	FW
Nov. 25	Intellego Board Member Addresses Doubts	FW
Nov. 24	Suspicions Against Former Intellego CEO Strengthen, Prosecutor Says	FW
Nov. 21	Former Intellego CEO Claes Lindahl Remanded in Custody	FW
Nov. 21	Intellego Technologies CEO Steps Down over Criminal Probe; Interim CEO Named	MT
Nov. 21	Nasdaq to Request Delisting of Intellego from First North	FW
Nov. 21	Intellego Has Until December 5 to Respond to Allegations	FW
Nov. 21	Nasdaq to submit request to delist Intellego shares	FW
Nov. 21	Intellego Appoints Jacob Laurin as Acting CEO Amid Criminal Investigation	FW
Nov. 21	Intellego appoints Jacob Laurin as interim CEO	RE

Chart Intellego Technologies AB

Duration

Period

INT: Dynamic Chart

Intellego Technologies AB is a Sweden-based company engaged in photochromatic indicator technology. The Company is a manufacturer of colorimetric ultraviolet indicators. UVC Dosimeters are used in Healthcare, Hospitality, Retail, Transportation and Commercial Applications around the world. With its patented photochromic ink that changes color based on exposure to ultraviolet irradiation or specific substances, Intellego produces dosimeters in a variety of formats and custom options to meet the constantly evolving needs of Ultraviolet Device Manufacturers (OEMs) and end-users. Intellego Technologies is headquartered in Stockholm, with product development and manufacturing based in the southwest region of Sweden.

Employees

Sector

Biotechnology & Medical Research

Calendar

Feb. 26 - Q4 2025 Earnings Release

More about the company